067370 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
SunBio, Inc. develops biosimilars, biopharmaceuticals, medical devices, and cosmetic products based on proprietary technologies comprised of site-directed pegylation of proteins, cell engineering technology, and novel pegylation technologies. The company was founded on June 10, 1997 and is headquartered in Gunpo-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
067370 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company